| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 6, 2026 | Conversion(C) | 2.0M | — | $0 | 2.0M |
| Aug 6, 2026 | Conversion(C) | 478K | — | $0 | 2.5M |
| Aug 6, 2026 | Buy(P) | 500K | $17.00 | $8.5M | 3.0M |
| Aug 5, 2026 | Sell(S) | 1K | $22.03 | $29K | 82K |
| Aug 5, 2026 | Sell(S) | 200 | $22.05 | $4K | 82K |
| Aug 5, 2026 | Sell(S) | 2K | $22.06 | $34K | 80K |
| Aug 5, 2026 | Sell(S) | 3K | $22.02 | $75K | 77K |
| Aug 5, 2026 | Sell(S) | 200 | $22.10 | $4K | 77K |
| Aug 5, 2026 | Sell(S) | 480 | $21.55 | $10K | 76K |
| Aug 5, 2026 | Sell(S) | 100 | $22.11 | $2K | 76K |
| Aug 5, 2026 | Sell(S) | 753 | $21.97 | $17K | 76K |
| Aug 5, 2026 | Sell(S) | 672 | $22.02 | $15K | 75K |
| Aug 5, 2026 | Sell(S) | 7K | $22.03 | $154K | 68K |
| Aug 5, 2026 | Sell(S) | 400 | $22.02 | $9K | 68K |
| Aug 5, 2026 | Sell(S) | 1K | $21.84 | $26K | 66K |
| Aug 5, 2026 | Sell(S) | 1K | $22.05 | $23K | 65K |
| Aug 5, 2026 | Sell(S) | 300 | $20.84 | $6K | 65K |
| Aug 5, 2026 | Sell(S) | 443 | $21.78 | $10K | 65K |
| Aug 5, 2026 | Sell(S) | 200 | $22.05 | $4K | 64K |
| Aug 5, 2026 | Sell(S) | 700 | $22.07 | $15K | 64K |
| Aug 5, 2026 | Sell(S) | 1K | $22.19 | $26K | 62K |
| Aug 5, 2026 | Sell(S) | 100 | $21.99 | $2K | 62K |
| Aug 5, 2026 | Sell(S) | 7K | $21.61 | $146K | 56K |
| Aug 5, 2026 | Sell(S) | 76K | $21.04 | $1.6M | 0 |
| Aug 5, 2026 | Buy(P) | 85K | $21.00 | $1.8M | 85K |
| Aug 5, 2026 | Sell(S) | 988 | $22.03 | $22K | 84K |
| Aug 5, 2026 | Sell(S) | 447 | $21.87 | $10K | 84K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 6, 2026 | Conversion(C) | 18.2M | — | $0 | 0 |
| Aug 6, 2026 | Conversion(C) | 4.4M | — | $0 | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001866174-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Attovia Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.